Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research ...

After the Trump administration froze federal funding, scientists are bracing for more potential disruptions to cancer trials.

Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the ...

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

A pause in communication is typical during a new administration’s transition. But some scientists fear that tying up NIH ...

While the National Institutes of Health employs 20,000-plus workers and spans 27 institutes and centers, the agency ... and a lack of communication from NIH leadership is fueling fears about ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.